Artificial Intelligence in Clinics Set to Transform Diagnostic Practices – ResearchAndMarkets.com
Smart In-Vitro Diagnostics Market Report Highlights the Growing Role of AI in Healthcare
New report from ResearchAndMarkets.com explores how artificial intelligence is transforming the in-vitro diagnostics (IVD) industry.
A new report titled “Smart In-Vitro Diagnostics Market – Artificial Intelligence for IVD Markets by Application, Technology, and User” has been released by ResearchAndMarkets.com, offering deep insights into the rapidly evolving smart diagnostics sector driven by artificial intelligence (AI).
As AI begins to move from research settings into clinical practice, smart diagnostics are increasingly being integrated into everyday medical care. This shift is enabling physicians to make more informed decisions and is also opening new pathways for pharmaceutical companies to develop and optimize therapies. The report explores whether smart diagnostics may eventually rival or even replace traditional physician-led diagnostic methods.
Key Report Highlights:
- Explosive Market Growth: The smart diagnostics market is expanding rapidly as demand for precision, speed, and cost-efficiency in diagnostics increases.
- Global Competition: Companies are racing to capture market share in this emerging field. Several players are already expanding on a global scale.
- Opportunities and Challenges: While AI-powered diagnostics offer premium pricing potential and continuous innovation, challenges remain in regulation, adoption, and technical integration.
Strategic Resources for Decision-Makers:
The report serves as a comprehensive tool for stakeholders, including executives, consultants, healthcare providers, and investors. It provides:
- Forecasts for emerging testing technologies
- Market size estimates across 18 countries and four regions
- Guidance for laboratory expansion planning
- A complete U.S. Medicare fee schedule for nucleic acid-based tests
Market Segmentation and Analysis:
The report covers market trends and forecasts across key applications such as:
- Oncology
- Infectious Diseases
- Cardiology
- Diabetes
- Anatomic Pathology
- General Medicine
It also explores the impact of various technologies including:
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Bioinformatics
- Digital pathology and AI-integrated platforms
Notable Industry Developments:
The report includes updates on major industry moves and product developments, such as:
- Launch of AI-based cancer diagnostics by Ataraxis AI and Tempus
- NHS adoption of digital pathology in the UK
- Viome Life Sciences’ $86.5M Series C funding round for AI cancer diagnostics
- Strategic partnerships like Paige.AI with Leica Biosystems, and Guardant Health with Lunit
Profiles of Leading Market Players:
More than 50 companies are profiled in-depth, including:
- Adaptive Biotechnologies
- Aidoc
- Caris Molecular Diagnostics
- Illumina
- NVIDIA
- Siemens Healthineers
- PathAI
- Sophia Genetics
- Viz.ai
Detailed Market Breakdown:
The report segments the global smart diagnostics market by:
- Application: Cancer, infectious disease, metabolic, cardiac, diabetes, and others
- Technology: NGS, PCR, immunoassays, pathology, and emerging tools
- End-Use Setting: Research labs, pharmaceutical research, clinical settings
Additional Resources:
An appendix includes Medicare reimbursement data, top-used IVD assays, and high-revenue tests in the U.S.
For more details, visit: ResearchAndMarkets.com
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and data, covering global industries, top companies, and emerging technologies.
